The year of publication showed a negligible correlation to the inclusion of ADEs, although a slight trend was observed with more recent publications excluding ADEs more often than older publications.
← all excerpts
Adverse drug events in cost-effectiveness models of pharmacological interventions for diabetes, diabetic retinopathy, and diabetic macular edema: a scoping review.
1
—
—